1 not yet recruiting, 1 recruiting, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Spinocerebellar Ataxia Type 1: new trials by email Literature Review of Spinocerebellar Ataxia Type 1 trials Research Report on Spinocerebellar Ataxia Type 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia Intravenous infusion, Intrathecal injection, umbilical cord mesenchymal stem cell - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2 | Phase 2 | Not yet recruiting | Sclnow Biotechnology Co., Ltd. | 45 | 2026-12-31 | 2026-04-23 |
| A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD VO659 - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3 | Phase 1 / Phase 2 | Recruiting | Vico Therapeutics B. V. | 68 | 2023-02-14 | 2026-08-19 |
| Study of CAD-1883 for Spinocerebellar Ataxia CAD-1883, Placebos - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1 | Phase 2 | Withdrawn | Cadent Therapeutics | 2021-06-01 | 2021-04-08 |
Machado-Joseph Disease (3) · Spinocerebellar Ataxias (3) · Ataxia (1) · Huntington Disease (1) · Olivopontocerebellar Atrophy V (1) · Spinocerebellar Ataxia 10 (1) · Spinocerebellar Degenerations (1) · Spinocerebellar ataxia 8 (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Cerebellar Ataxia (3) · Cerebellar Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Dyskinesias (3) · Genetic Diseases, Inborn (3) · Heredodegenerative Disorders, Nervous System (3) · Nervous System Diseases (3) · Neurodegenerative Diseases (3) · Neurologic Manifestations (3) · Spinal Cord Diseases (3) · Ataxia (2) · Spinocerebellar Degenerations (2) · Basal Ganglia Diseases (1)
Infusions, Intravenous (1) · Injections, Spinal (1)
Cadent Therapeutics (1) · Sclnow Biotechnology Co., Ltd. (1) · Vico Therapeutics B. V. (1)
Denmark (1) · France (1) · Germany (1) · Israel (1) · Netherlands (1) · United Kingdom (1) · United States (1)
Hong Jiang (1)